← All trials
NCT05226429
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 8, 2022
- Primary completion
- Apr 6, 2023
- Completion date
- Jul 6, 2023
- First posted
- Feb 7, 2022
- Last posted
- Aug 26, 2022
- Enrollment
- 495
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Dr. Soetomo General HospitalLead sponsor
- Government of IndonesiaCollaborator
- Airlangga UniversityCollaborator
- Dr. Soetomo General HospitalOverall official - principal investigator
- Dr. Soetomo General HospitalReponsible party - principal investigator
- Biotis Pharmaceuticals, IndonesiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.